67th Day Of Lockdown

Maharashtra62228269972098 Tamil Nadu2024611313157 Delhi173877846398 Gujarat159448611980 Rajasthan83654855184 Madhya Pradesh76454410334 Uttar Pradesh74454215201 West Bengal48131775302 Bihar3359120915 Andhra Pradesh3330223460 Karnataka278189448 Telangana2256134567 Punjab2197194942 Jammu and Kashmir216487528 Odisha17239779 Haryana172194019 Kerala11515659 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chandigarh3641894 Chhatisgarh364830 Tripura2421650 Himachal Pradesh223634 Goa68370 Puducherry49170 Meghalaya20121 Nagaland1800 Manipur540 Arunachal Pradesh210 Mizoram110 Sikkim100
Science 14 Apr 2020 Antiviral drug remde ...

Antiviral drug remdesivir could stop coronavirus from replicating, says ICMR

PTI
Published Apr 14, 2020, 1:51 pm IST
Updated Apr 14, 2020, 1:51 pm IST
In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require ventilator support
n this March 2020 photo provided by Gilead Sciences, a vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Photo | AP)
 n this March 2020 photo provided by Gilead Sciences, a vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Photo | AP)

New Delhi: The Indian Council of Medical Research on Monday said antiviral drug remdesivir, which was used during the Ebola outbreak, may be highly effective in stopping the replication mechanism of SARS-CoV-2 that causes COVID-19.

The ICMR said research on its efficacy in the treatment of COVID-19 is a part of WHO's "Solidarity Trial".

 

According to a recently published study in the New England Journal of Medicine, two out of three critically ill coronavirus infected patients who were on oxygen support or on ventilators showed signs of improvement when they were administered remdesivir.

Commenting on the study, Head of Epidemiology and Communicable diseases at ICMR Raman R Gangakhedkar said that drug which was used against Ebola virus, according to the researchers, hinders the reproduction of coronavirus which is why they believe that it could be effective in COVID-19 treatment.

"A recently reported study on use of remdesivir for COVID-19 treatment is not a clinical trial, but an observational study which found that 68 per cent or two out of three patients after treatment with the drug did not require ventilator support or their need for oxygen support reduced. We will come to know of further developments through the WHO Solidarity Trial, which has an arm which is looking into this," he said.

He further said that remdesivir, developed by Gilead Sciences Inc, is not presently available in the country and the government is working on to see if  any pharmaceutical company can manufacture it.

Click on Deccan Chronicle Technology and Science for the latest news and reviews. Follow us on Facebook, Twitter

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT